MINNEAPOLIS, Jan. 12, 2017 -- Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announced today that management will hold a conference call on January 19, 2017 to provide a business update and a discussion on recent and upcoming milestones.
The conference call is scheduled to begin at 4:30 p.m. (Eastern Time).
To access the conference call, U.S.-based listeners should dial 844-666-7589 and international listeners should dial 443-961-0433. All listeners should provide the following passcode: 49910217.
Following the conclusion of the conference call, a replay will be available through January 25, 2017 and can be accessed by dialing (855) 859-2056 from within the U.S. or (404) 537-3406 from outside the U.S. All listeners should provide passcode 49910217.
About Skyline Medical Inc.
Skyline Medical Inc. produces a fully automated, patented, FDA-cleared, waste fluid disposal system that virtually eliminates staff exposure to blood, irrigation fluid and other potentially infectious fluids found in the healthcare environment. Antiquated manual fluid handling methods — which require hand carrying and emptying filled fluid canisters — present an exposure risk and potential liability. Skyline Medical's STREAMWAY System fully automates the collection, measurement and disposal of waste fluids and is designed to: 1) reduce overhead costs to hospitals and surgical centers, 2) improve compliance with OSHA and other regulatory agency safety guidelines, 3) improve efficiency in the operating room, and radiology and endoscopy departments — leading to greater profitability, and 4) provide greater environmental stewardship by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United States. For additional information, please visit www.skylinemedical.com.
Contact: Investors LHA Kim Sutton Golodetz (212) 838-3777 [email protected] MoneyInfo, LLC Charles Moskowitz (781) 826-8882 [email protected]


OpenAI Explores Massive Funding Round at $750 Billion Valuation
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 



